Cargando…
Live Attenuated Vaccine Based on Duck Enteritis Virus against Duck Hepatitis A Virus Types 1 and 3
As causative agents of duck viral hepatitis, duck hepatitis A virus type 1 (DHAV-1) and type 3 (DHAV-3) causes significant economic losses in the duck industry. However, a licensed commercial vaccine that simultaneously controls both pathogens is currently unavailable. Here, we generated duck enteri...
Autores principales: | Zou, Zhong, Ma, Ji, Huang, Kun, Chen, Huanchun, Liu, Ziduo, Jin, Meilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056193/ https://www.ncbi.nlm.nih.gov/pubmed/27777571 http://dx.doi.org/10.3389/fmicb.2016.01613 |
Ejemplares similares
-
Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
por: Zou, Zhong, et al.
Publicado: (2017) -
Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection
por: Zou, Zhong, et al.
Publicado: (2015) -
Recombinant Duck Enteritis Virus-Vectored Bivalent Vaccine Effectively Protects Against Duck Hepatitis A Virus Infection in Ducks
por: Yang, Fuchun, et al.
Publicado: (2021) -
Efficient Strategy to Generate a Vectored Duck Enteritis Virus Delivering Envelope of Duck Tembusu Virus
por: Zou, Zhong, et al.
Publicado: (2014) -
Pathogenicity and transmissibility studies on live attenuated duck enteritis virus vaccine in non-target species
por: Kong, Jie, et al.
Publicado: (2022)